Sell-down IPO vs capital-raising IPO: which suits a serial acquirer?

What is the difference between a sell-down IPO and a capital-raising IPO?

In a capital-raising (primary) IPO, the company issues new shares and receives the money. Existing owners are diluted. In a sell-down (secondary) IPO, existing holders sell shares they already own. The company issues nothing and receives nothing, and the owners get cash. Many offerings mix the two.

A serial acquirer cares because it buys businesses continuously. New money can pay for deals. A listing without new money still gives it a quoted stock and a broader shareholder base. See what a serial acquirer is.

What did Röko disclose?

Röko is a Swedish serial acquirer that listed class B shares on Nasdaq Stockholm. Nasdaq Stockholm is not the U.S. Nasdaq, and its rules differ. Röko's announcements state:

• The offering comprised only existing shares, up to 2,580,257 class B shares or about 17.6% of the total. At SEK 2,048 a share, the offering was worth about SEK 5,284 million (March 4 and 11, 2025).
• 69 existing shareholders sold, mostly small parts of their holdings. The prospectus announcement states that no board or management member was selling.
• The company stated that it "did not raise any funds" (March 11, 2025). Trading began that day as ROKO B.
• Its stated reasons were to broaden the ownership base, give access to Swedish and international capital markets, and raise awareness that may bring more acquisition opportunities.
• For the year ended December 31, 2024: net sales of SEK 6,182 million, adjusted EBITA of SEK 1,227 million (a 20% margin), and financial net debt of 2.1 times adjusted EBITDA, against 2.2 times in 2023 and 4.2 times in 2022.
• Lockups: 1,080 days for the founders and Johan Bladh, 360 days for other board members and management, and 180 days for other existing shareholders.

The full account is in Röko: a 2025 serial-acquirer IPO that raised no new money.

What did Lifco disclose?

Lifco's 2014 offering memorandum and its history page state:

• The seller was its principal shareholder, Carl Bennet AB. The offering was existing series B shares at SEK 93, and the memorandum says no new shares would be issued.
• The base offering was 34,602,400 shares. With an expansion option of 6,606,700 and an over-allotment option of 4,120,900, the maximum was 45,330,000 shares. Lifco's history page says Carl Bennet AB sold 49.9% of the shares.
• Shortly before the offering the company obtained an unconditional shareholders' contribution of MSEK 500 from the principal shareholder. The memorandum says the purpose was to strengthen expansion prospects and the balance sheet. Offering and listing costs were estimated at about MSEK 110.
• Trading began on Nasdaq Stockholm on November 21, 2014. At the end of 2025 the group had 275 operating companies in 37 countries, per its history page.

So a sell-down did not mean the company got no capital. The seller funded the balance sheet separately. See Lifco: a controlled, decentralized compounder.

When does a sell-down suit a serial acquirer?

My view is that a sell-down fits when three things are true:

• Cash flow and debt capacity already cover the deal pipeline. Röko's 2.1 times financial net debt to adjusted EBITDA at the end of 2024 shows one company's level, not a target.
• The owners want liquidity, or the company wants a quoted stock and a wider holder base.
• The owners are willing to stay in. Röko's founders accepted a 1,080-day lockup, and Lifco's seller was to keep about 50.1% if every option was exercised.

When does it need new money?

When the deal pipeline is larger than cash flow plus the debt a lender will provide. Selling new shares then pays for deals without adding debt. The cost is dilution, so test it against your hurdle rate. See what hurdle rate a serial acquirer should use and how much debt a public serial acquirer can carry.

What changes for a U.S. listing?

• Float. The Nasdaq Capital Market requires $15 million of unrestricted publicly held shares under each financial standard, and a March 2025 amendment says an IPO company must meet that with offering proceeds. I did not find language in the SEC order on whether shares sold by selling shareholders count. Ask Nasdaq staff. See Nasdaq's 2026 listing requirements.
• Restricted shares. Shares under lockup are not unrestricted, so they do not count toward the float.
• Stock as currency. A quoted stock helps with seller stock. See how to use public stock to buy private businesses.

What does the math look like?

Assumptions, all hypothetical: 10,000,000 shares owned by the founders, priced at $5.00 for a $50 million equity value. The offering is $15 million gross with an assumed 7% underwriting discount, or $1,050,000.

• Net to whoever sells: $15,000,000 - $1,050,000 = $13,950,000, before other costs.
• Capital-raising: 3,000,000 new shares ($15,000,000 / $5.00). Shares after: 13,000,000. Founders own 10,000,000 / 13,000,000 = 76.9%. The company holds $13.95 million of new cash. Value after: 13,000,000 x $5.00 = $65 million.
• Sell-down: founders sell 3,000,000 of their shares. Shares after: 10,000,000. Founders own 7,000,000 / 10,000,000 = 70%. They receive $13.95 million and the company receives nothing. Value after: $50 million.
• Illustration of debt-only capacity: at 2.1 times (Röko's ratio, used only as an example) and an assumed $6 million of EBITDA, net debt would be 2.1 x $6,000,000 = $12.6 million.

The sell-down gives the founders cash and a lower stake. The capital-raising version gives the company cash and a higher founder stake. Which is better depends on whether the company can use $13.95 million at a return above its cost of capital.

Where these numbers come from: Röko facts are from its March 4, 2025 prospectus announcement, its March 11, 2025 outcome announcement and its English prospectus release. Lifco facts are from its November 7, 2014 offering memorandum, its December 17, 2014 press release and its history page. The Nasdaq float amendment is in SEC Release 34-102622. The offering example, the 7% discount and the EBITDA are hypothetical.

Related questions

Can a company that raises nothing still benefit from an IPO?

Röko's stated reasons were a broader owner base, access to capital markets and awareness that may bring deals. Whether that is worth the cost is your call.

Do founders have to sell in a sell-down?

No. Röko's prospectus announcement says no board or management member was selling, and Lifco's seller kept about half of the shares.

Can the offering mix both kinds of shares?

Yes. An offering can include both new and existing shares. I did not find a rule that blocks a mix, but the Nasdaq float question above applies to both parts.

What comes next

For the full facts on the Swedish example, read Röko: a 2025 serial-acquirer IPO that raised no new money.

Related articles

• Lifco: a controlled, decentralized compounder
• OTCQB to Nasdaq: what does a holdco need to uplist?
• Should a holding company go public, and at what size?
• What is a permanent capital vehicle, and can a small company be one?
• Is a direct listing still a good way for a small company to go public in 2026?

Meraki Dealmakers is a service of Meraki Partners, LLC, an advisory firm. It is not a broker-dealer, investment adviser, business broker, law firm or accounting firm. This article is general information, not legal, tax or investment advice.